Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

(2020) Manli Wang et al.   CELL RESEARCH

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis

(2020) M. Drent et al.   LUNG

Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses

(2020) Jieliang Chen   MICROBES AND INFECTION

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

(2020) Alfred H.J. Kim et al.   ANNALS OF INTERNAL MEDICINE

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

(2020) Xueting Yao et al.   CLINICAL INFECTIOUS DISEASES

Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association

(2020) Dhanunjaya R. Lakkireddy et al.   HEART RHYTHM

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

(2020) Jianjun Gao et al.   BioScience Trends

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

(2020) Jia Liu et al.   Cell Discovery

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

(2020) Andrea Cortegiani et al.   JOURNAL OF CRITICAL CARE

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

(2020) J.M. Molina et al.   MEDECINE ET MALADIES INFECTIEUSES

A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients

(2019) Angel Arnaout et al.   BREAST CANCER RESEARCH AND TREATMENT

Prévalence des effets indésirables de l’hydroxychloroquine (Plaquenil ® ) dans une population dermatologique : étude rétrospective sur 102 patients

(2018) P. Tétu et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Hydroxychloroquine retinopathy — implications of research advances for rheumatology care

(2018) April Jorge et al.   Nature Reviews Rheumatology

Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?

(2017) AMAR SRINIVASA et al.   JOURNAL OF RHEUMATOLOGY

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)

(2016) Michael F. Marmor et al.   OPHTHALMOLOGY

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

(2015) S. De Carolis et al.   AUTOIMMUNITY REVIEWS

Emerging strategies to effectively target autophagy in cancer

(2015) V W Rebecca et al.   ONCOGENE

Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS

(2015) Andrea Savarino et al.   Retrovirology

Ebola Virus and Severe Acute Respiratory Syndrome Coronavirus Display Late Cell Entry Kinetics: Evidence that Transport to NPC1+Endolysosomes Is a Rate-Defining Step

(2015) Rebecca M. Mingo et al.   JOURNAL OF VIROLOGY

Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner

(2014) Christine Burkard et al.   PLoS Pathogens

Chloroquine cardiomyopathy – a review of the literature

(2013) Ernst Tönnesmann et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus Erythematosus

(2013) Nadia D. Morgan et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Hydroxychloroquine: From Malaria to Autoimmunity

(2011) Ilan Ben-Zvi et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action

(2011) Steven J Katz et al.   CURRENT OPINION IN RHEUMATOLOGY

Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study

(2010) Senol KOBAK et al.   International Journal of Rheumatic Diseases